Physician's Weekly4d
Patient-Performed Functional Tests Reliable in Idiopathic Inflammatory Myopathies
Patient-performed functional tests were found to be reliable, scalable options for assessing muscle function in idiopathic inflammatory myopathies.
Zacks Investment Research on MSN4d
Alnylam Gets FDA Nod for Expanded Use of Amvuttra in Cardiomyopathy
Alnylam Pharmaceuticals ALNY announced that the FDA had approved its regulatory filing seeking the label expansion of its ...
European Medical Journal13d
Rare Anti-HMGCR-Induced Immune-Mediated Necrotising Myopathy: A Case Report and Literature Review
An acute necrotising myopathy is a distinct form of uncommon muscle disease characterised by the rapid advancement of ...
Healio4d
FDA approves vutrisiran for ATTR amyloidosis with cardiomyopathy
Alnylam announced the FDA approval of its supplemental new drug application for vutrisiran, an RNA interfering small molecule ...
Medscape4d
FDA Expands Vutrisiran Indication to ATTR-Cardiomyopathy
The FDA has approved a supplemental new drug application for the treatment of cardiomyopathy wild-type or hereditary ...
Heart4d
Cardiac disease monitoring measures in patients with transthyretin amyloid cardiomyopathy treated with tafamidis
Background Patients with transthyretin amyloid cardiomyopathy (ATTR-CM) often experience worsening cardiac disease (WCD) ...